Date post: | 26-Dec-2015 |
Category: |
Documents |
Upload: | maximilian-price |
View: | 216 times |
Download: | 0 times |
2
Presentation
Our presentation will explain and justify our request for a $765,000 investment from Ohio Tech Angels’ Fund 2 for our business.
3
About Us
Premier cancer information and technology company
Founded 2009 in Zanesville, OH Founders have combined 100 years
experience in oncology and cosmetic surgery, nursing, exercise physiology and gerontology
4
Our Mission
To increase the awareness of how cancer affects individuals at an increasing rate and decrease morbidity associated with the disease through early detection. We believe that increased availability and understanding within the population will decrease cancer rates and risk while increasing early detection.
5
Our Vision
To become a leader in cancer patient advocacy and hasten the day when all people with disabilities have equal access to cancer-related information.
6
Customer Market
This may lead to Misdiagnoses Non-treatment Lack of
communication between physician and patient
Source: College of Communications on Health Communications.
20%
80%
Cancer Patients
Satisfied
Not Satisfied
7
Target Audience
Therefore our audience will be Physical Model – People with all types of
disabilities. Web site - General public looking for
easy to understand information concerning cancer; its causes and prevention.
Database - Medical-related staff, researchers and educators.
8
Initial Product Offerings
Sample of information that will be found on our web site includes multi-sensory adaptations for:
Audio Closed Captioning Photo Lower Literacy Level Communications
Physical 3D models of the two most prevalent forms of breast cancer.
9
Secondary Product Offering
Cancer-related data will be collected at the start up.
Data will be available in year 2. Ohio Appalachian regions data will be
ready first 1st East-Central, 2nd South-East, 3rd
Southern Expansion into Eastern Kentucky and
West Virginia Starting with breast cancer in men and
women then expansion to other types of cancer
11
Patient #10-9809 Invasive Ductal Carcinoma
•Tumors look like lumps•80% of people with breast cancer have this type of cancer•Avoidance•Early Detection•Ways to treat it include
N.B. – notice simplified language for patients with lower literacy levels
13
Patient #10-9803 Globular Carcinoma
•Cancer that feels like a small pea in the breast•10 % of people with breast cancer have this type of cancer•Avoidance•Early Detection•Ways to treat it include…
14
Prototypes
Website http://4mcancerinc.110mb.com/index.ht
ml
Physical Model
Data Samples
15
Data Sample
Traits ID – 09-00041
Gender Male Alcohol Consumption
1 drink per day
Age 69 Smoking/Tobacco
None
Race Asian Drug Use None
Children No Family Cancer History
Father – renal
Income $20-29,999 Breast Feeding n/a
Socioeconomic
Low-Mid Class
Cultures n/a
Education High School BMI 34.0
Yearly Screening
No I/D in Weight None
Insured Yes Diet History None
Notes n/a Serum Ca++ Levels
10.1 ± 1.7 U/ml
17
Inception
After we established the need for our products we decided on a physical model, a web site, and cancer-related data.
Initial prototype costs were established and web page development began.
After establishing the need, this is the initial offering that will allow us entrance into an untapped and underserviced market.
18
Development
We are proposing development of two physical models and will be contracting with local plastic fabricators for mold development and preparation for mass production.
Simultaneous web page development.
We are collecting and categorizing information for dissemination.
19
Production
Following initial cost for mold development and examination for quality, production can begin with an initial order of 2,160 of the physical models.
Professional focus groups will authenticate web site information.
Web site will go live with active solicitation of advertising and other funding sources for support of the web site.
20
Marketing
By contracting with top 8 medical vendors marketing costs for the physical model will be reduced.
Our marketing dollars will be invested in trade shows, product technology development, and outreach to encatchment areas.
The outreach through our web pages will be worldwide and will support both the physical model and the educational goals.
21
Sales
Number of Units
Price Per Annum
Starting Year 2
Subscribers
180 $1,200 $216,000
Monthly Advertisers
75 $500 $450,000
Monthly Models Sold
180 $249 $573,840
22
Financials – Cash Flow Summary 0%
Payback Period
Discount Rate Year 0 Year 1 Year 2 Year 3 Year 4 Year 5
Total inflows $ 987,840 $ - $ 987,840 $1,282,867
$1,389,817
$1,505,754
$ 1,631,441
Total outflows $(606,295) $ (763,590) $(606,295) $(879,717) $(920,061) $(956,420) $(993,850)
Net cash flow $381,545 $(763,590) $ 381,545 $ 403,150
$ 469,755
$ 549,334 $ 637,591
Cumulative Net cash flow $381,545
$ (763,590) $(382,045) $21,105 $490,860
$1,040,194
$1,677,785
23
Intrinsic Values
The non-financial values are incalculable in terms of lives saved and changed and increase in the quality of life.
24
Risks
Not being able to get product into market
Resellers drop our product Patent research isn’t done properly Sales impacted by new research in
field Our technology doesn’t keep up with
trends
25
Risk Avoidance and Mitigation Research all resellers who can get our
product to market Multiple revenue streams can cover
variances in others Hire qualified patent attorneys Keep abreast of research trends in the
cancer fields Test software as future OS, browsers
are released
26
Conclusion
With our knowledge, research, sales figures and risk analysis 4M Cancer, Inc. is worthy to receive start up funds.
27
Request
We request $765,000 from the Ohio Tech Angels Fund 2 under technology and health for the startup costs of 4M Cancer, Inc.